OFFICIAL LEGAL TITLE
PrEP Access and Coverage Act of 2026
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 119_S_3990.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2026-03-04.
What are the main provisions?
Key points include:
- Zero cost-sharing (no copays or deductibles) for PrEP drugs, laboratory tests, and clinical follow-up visits.
- Prohibition on life, disability, and long-term care insurers from denying coverage based on PrEP use.
- Insurers cannot increase premiums or change policy conditions solely because an individual takes HIV prevention medication.
- Enhanced privacy protections ensuring family plan members can access prevention services without the primary policyholder being notified.
- A private right of action allowing citizens to sue insurance companies in court for violations of these new rights.
What is the specific legal status?
The current status is Introduced.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Smith, Tina [D-MN].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-03-19.
What is the impact of this bill?
We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.